255 related articles for article (PubMed ID: 24487392)
1. Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.
Basma H; Gunji Y; Iwasawa S; Nelson A; Farid M; Ikari J; Liu X; Wang X; Michalski J; Smith L; Iqbal J; El Behery R; West W; Yelamanchili S; Rennard D; Holz O; Mueller KC; Magnussen H; Rabe K; Castaldi PJ; Rennard SI
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L552-65. PubMed ID: 24487392
[TBL] [Abstract][Full Text] [Related]
2. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
[TBL] [Abstract][Full Text] [Related]
4. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
[TBL] [Abstract][Full Text] [Related]
5. Zic3 enhances the generation of mouse induced pluripotent stem cells.
Declercq J; Sheshadri P; Verfaillie CM; Kumar A
Stem Cells Dev; 2013 Jul; 22(14):2017-25. PubMed ID: 23421367
[TBL] [Abstract][Full Text] [Related]
6. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
8. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells from goat fibroblasts.
Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
11. Human-induced pluripotent stem cells produced under xeno-free conditions.
Ross PJ; Suhr ST; Rodriguez RM; Chang EA; Wang K; Siripattarapravat K; Ko T; Cibelli JB
Stem Cells Dev; 2010 Aug; 19(8):1221-9. PubMed ID: 20030562
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
13. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.
Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H
Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921
[TBL] [Abstract][Full Text] [Related]
14. Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate.
Yamaguchi S; Hirano K; Nagata S; Tada T
Stem Cell Res; 2011 Mar; 6(2):177-86. PubMed ID: 21130722
[TBL] [Abstract][Full Text] [Related]
15. Generation of transgene-free porcine intermediate type induced pluripotent stem cells.
Li D; Secher J; Hyttel P; Ivask M; Kolko M; Hall VJ; Freude KK
Cell Cycle; 2018; 17(23):2547-2563. PubMed ID: 30457474
[TBL] [Abstract][Full Text] [Related]
16. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.
Hu S; Wilson KD; Ghosh Z; Han L; Wang Y; Lan F; Ransohoff KJ; Burridge P; Wu JC
Stem Cells; 2013 Feb; 31(2):259-68. PubMed ID: 23136034
[TBL] [Abstract][Full Text] [Related]
19. Generation of stable pluripotent stem cells from NOD mouse tail-tip fibroblasts.
Liu J; Ashton MP; Sumer H; O'Bryan MK; Brodnicki TC; Verma PJ
Diabetes; 2011 May; 60(5):1393-8. PubMed ID: 21464439
[TBL] [Abstract][Full Text] [Related]
20. Generation of induced pluripotent stem cells from conjunctiva.
Yang J; Li Y; Erol D; Wu WH; Tsai YT; Li XR; Davis RJ; Tsang SH
Graefes Arch Clin Exp Ophthalmol; 2014 Mar; 252(3):423-31. PubMed ID: 24492934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
